Single cell atlas of canine natural killer cells identifies distinct circulating and tissue resident gene profiles.
Razmara AM, Lammers M, Judge SJ, Murphy WJ, Gaskill CE, Culp WTN, Gingrich AA, Morris ZS, Rebhun RB, Brown CT, Vail DM, Kent MS, Canter RJ.Front Immunol. 2025 May 15;16:1571085. doi: 10.3389/fimmu.2025.1571085. eCollection 2025.PMID: 40443661
Characterizing Plasma-Based Metabolomic Signatures for Metastasis in Non-Small Cell Lung Cancer.
Liu M, Zhu Y, McIlwain SJ, Deng H, Brasier AR, Ge Y, Kimple ME, Baschnagel AM.Metabolites. 2025 May 20;15(5):340. doi: 10.3390/metabo15050340.PMID: 40422916
Twist1-induced suppression of oncogene-induced senescence in non-small cell lung cancer requires the transactivation domain of Twist1.
Lafargue A, Wang H, Chettiar ST, Gajula RP, Shetty AC, Song Y, Simons BW, Khan MA, Nguyen T, Tseng HW, Chang J, Waters DN, Chan A, Lam C, Carrieri FA, Smack C, Connis N, Chowdhury DD, Nugent K, Siddiqui I, Taparra K, Rezaee M, Zachara N, Morris ZS, McFarland C, Abdulkadir SA, Hann CL, Tran PT.Neoplasia. 2025 May 22;66:101179. doi: 10.1016/j.neo.2025.101179. Online ahead of print.PMID: 40409044
Identifying prognostic targets in metastatic prostate cancer beyond AR.
Feng E, Feng E, Berg T, Nguyen IS, Nguyen LG, Chen W, Zhang M, Quigley D, Sharifi M, Li H, Coleman I, Nelson PS, Sjöström M, Zhao SG.FEBS Open Bio. 2025 May 22. doi: 10.1002/2211-5463.70059. Online ahead of print.PMID: 40405591
Retrospective analysis and IMRT replanning of a 3D-CRT murine dose painting study for preclinical oxygen-guided radiotherapy.
Tummala R, Pearson E, Antes A, Slagowski JM, Redler G, Nilsson R, Halpern HJ, Sarigul N, Ahmed I, Velarde DO, Epel B, Gertsenshteyn I, Aydogan B.Sci Rep. 2025 May 22;15(1):17755. doi: 10.1038/s41598-025-01716-6.PMID: 40404740
Tumor-associated MerTK promotes a pro-inflammatory microenvironment and enhances immune checkpoint inhibitor response in triple-negative breast cancer.
Crossman BE, Harmon RL, Iida M, Adams JM, Lin CY, Glitchev CE, Juang TD, Kerr SC, Alexandridis RA, Hyun M, Yang DT, Kang I, Salgia R, Wheeler DL.Front Oncol. 2025 May 5;15:1579214. doi: 10.3389/fonc.2025.1579214. eCollection 2025.PMID: 40391157
The Cut-Sort-Group algorithm for efficient delivery of collimated step-and-shoot proton arc therapy.
Wake KK, Bennett LC, Smith BR, Culberson WS, Hyer DE, Flynn RT, Patwardhan KA, Nelson NP, Hill PM.Med Phys. 2025 May 19. doi: 10.1002/mp.17889. Online ahead of print.PMID: 40387498
Clinicopathologic and Molecular Characterization of SMARCB1-Deificient Sinonasal Carcinomas -A Systematic Study from a Single Institution Cohort.
Li Q, Abi-Saab T, Prilutskiy A, Horner V, Frater-Rubsam L, Peng Y, Huang W, Kimple RJ, Harari PM, Lloyd RV, Hu R.Head Neck Pathol. 2025 May 14;19(1):60. doi: 10.1007/s12105-025-01788-w.PMID: 40366517
Implementation of a novel pencil beam scanning Bragg peak FLASH technique to a commercial treatment planning system.
Bookbinder A, Krieger M, Lansonneur P, Magliari A, Zhao X, Choi JI, Simone CB 2nd, Lin H, Folkerts M, Kang M.Med Phys. 2025 May 8. doi: 10.1002/mp.17876. Online ahead of print.PMID: 40344192
Software Support Tools for Reirradiation: A Report From Reirradiation Collaborative Group (ReCOG) 2024.
Matrosic CK, Andrzejewski P, Bergman A, Chng N, Naqa IE, Freislederer P, Hoffmann L, Hope A, Jacqmin D, Kelly C, Kuo L, Lin H, Mayo C, Murrell DH, Ödén J, Svensson S, Thompson S, Osorio EV, West N, Wicha R, Yorke E, Appelt AL, Paradis KC.Int J Radiat Oncol Biol Phys. 2025 May 1;122(1):181-185. doi: 10.1016/j.ijrobp.2024.12.023.PMID: 40240108 No abstract available.
An ultra-high dose rate Bragg peak tracking technique provides more affordable proton radiotherapy for cancer patients: From principle to experimental validation.
Wei S, Lin H, Cheng C, Choi JI, Simone CB 2nd, Kang M.Radiother Oncol. 2025 May;206:110800. doi: 10.1016/j.radonc.2025.110800. Epub 2025 Feb 21.PMID: 39988304
Predicting dose response to prostate cancer radiotherapy: validation of a radiation signature in the randomized phase III NRG/RTOG 0126 and SAKK 09/10 trials.
Dal Pra A, Ghadjar P, Ryu HM, Proudfoot JA, Hayoz S, Michalski JM, Spratt DE, Liu Y, Schär C, Berlin AM, Zwahlen DR, Simko JP, Hölscher T, Efstathiou JA, Polat B, Sandler HM, Hildebrandt G, Parliament MB, Mueller AC, Dayes IS, Plasswilm L, Correa RJM, Robertson JM, Karrison TG, Davicioni E, Hall WA, Feng FY, Pollack A, Thalmann GN, Nguyen PL, Aebersold DM, Tran PT, Zhao SG.Ann Oncol. 2025 May;36(5):572-582. doi: 10.1016/j.annonc.2025.01.017. Epub 2025 Feb 13.PMID: 39986927